blood, but the Wilcoxon signed-rank test indicated no significant difference between the number of exclusive variants with specific characteristics (frameshift, pathogenic and likely pathogenic, uncertain significance, AR, BRCA2, MUC16, exonic, AF <1%, AF 1–5%) isolated from WB compared to variants isolated from CTC-depl. The gene discussed is AR; the disease is atrial fibrillation.